CAI

Caris Life Sciences, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-03

Figures on this page computed 2026-11-08 12:40 UTC

Last close

25.23USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-03

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-03
The filing itself
21.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
-8.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
8.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
0.74Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

325

2015-12-31 to 2025-12-31100 at the start325

Sales: 100.00 on 2015-12-31 to 325.25 on 2025-12-31, up 225%.

Profit

-254

2015-12-31 to 2025-12-31100 at the start-254

Profit: 100.00 on 2015-12-31 to -253.70 on 2025-12-31, down 354%.

Shares in issue

797

2015-12-31 to 2025-12-31100 at the start797

Shares in issue: 100.00 on 2015-12-31 to 796.67 on 2025-12-31, up 697%.

Sales is at 325, Profit is at -254, Shares in issue is at 797, against 100 in 2015.

Sales is at 325, Profit is at -254, Shares in issue is at 797, against 100 in 2015.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-03

Sales, where the first year is 100325
Source
filed
Statement
income
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
The filing itself
Profit, where the first year is 100-254
Source
filed
Statement
income
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
The filing itself
Shares in issue, where the first year is 100797
Source
filed
Statement
income
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
The filing itself